In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- 23 September 1999
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 35 (1) , 37-44
- https://doi.org/10.1016/s0732-8893(99)00053-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In Vitro Activities of the Ketolide HMR 3647 against Recent Gram-Positive Clinical Isolates and Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1998
- Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility statusJournal of Antimicrobial Chemotherapy, 1998
- Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)Antimicrobial Agents and Chemotherapy, 1998
- Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other AgentsAntimicrobial Agents and Chemotherapy, 1998
- Ketolides lack inducibility properties of MLS(B) resistance phenotypeJournal of Antimicrobial Chemotherapy, 1997
- In-vitro activity of ketolides against mycoplasmasJournal of Antimicrobial Chemotherapy, 1997
- Antimicrobial activity of RU-66647, a new ketolideDiagnostic Microbiology and Infectious Disease, 1997
- Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance studyAntimicrobial Agents and Chemotherapy, 1996